After a thorough consideration, Pfizer Inc. $PFE announced on Monday that it would not split its business. The drug-maker had an �extensive evaluation� to assess the feasibility of a potential split of the business into two units (Pfizer Innovative Health and Pfizer Essential Health), and its impact on the shareholder value. It reaffirmed its financial guidance given on August 2.